Safety of Intravenous Immunoglobulin (Tegeline®), Administered at Home in Patients with Autoimmune Disease: Results of a French Study

The efficacy of intravenous immunoglobulins (IVIg) in patients with autoimmune diseases (AID) has been known for several decades. Majority of these patients received IVIg in hospital. A retrospective study was conducted in 22 centers in France to evaluate the feasibility of the administration of Teg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Res Int
Main Authors: Hachulla, Eric, Le Masson, Gwendal, Solé, Guilhem, Hamidou, Mohamed, Desnuelle, Claude, Azulay, Jean-Philippe, Besson, Gérard, Swiader, Laure, Abad, Sébastien, Antoine, Jean-Christophe, Bouhour, Françoise, Créange, Alain, Grenouillet, Marike, Magy, Laurent, Marcel, Sébastien, Paquet, Jean-Michel, Rouhart, François, Ziegler, François, Mathis, Stéphane, Gauthier-Darnis, Marc, Puget, Sophie
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5875056/
https://ncbi.nlm.nih.gov/pubmed/29736397
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/8147251
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados